// App-Quantinova.ai

TCT-50 : Angiographic Predictor of 2-Year Stent Thrombosis in Patients Receiving Drug-eluting Stents: Insights from the ADAPT-DES Study

Researchers

Presenter

  • Philippe Genereux

Principal Investigators

  • Ajay J. Kirtane

  • Bernhard Witzenbichler

  • Laura Lasalle

  • Giora Weisz

  • Ke Xu

  • Sorin Brener

  • Roxana Mehran

  • Gregg W. Stone

Medical Centers

  • Charite Campus Benjamin Franklin, Berlin, Germany.

  • Department of Pediatrics, New York Methodist Hospital, Brooklyn, NY

  • Mount Sinai Hospital, New York, NY

  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY

  • Cardiovascular Research Foundation, Orangeburg, NY

Locations

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Clopidogrel bisulfate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved